Clearance of vancomycin during high-volume haemofiltration: Impact of pre-dilution

Shigehiko Uchino, Louise Cole, Hiroshi Morimatsu, Donna Goldsmith, Rinaldo Bellomo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objective: To measure the sieving coefficient (SC) and clearance of vancomycin during high-volume haemofiltration (HVHF) and to evaluate the impact of different pre-dilution regimens on these variables. Design and setting: Prospective interventional study in the intensive care unit in a tertiary university hospital. Patients: Seven patients with septic shock and multi-organ dysfunction. Interventions: HVHF (6 l/h fluid exchange) was performed in septic shock patients using variable proportions of their replacement fluid in pre- and post-dilution mode. Measurements and results: Pre-filter, post-filter and ultrafiltrate vancomycin concentrations were measured simultaneously, and SC and clearance calculated. The measurements were repeated following each change in the proportion of pre-dilution fluid. SC steadily decreased as the proportion of pre-dilution decreased, changing from 0.76 in pure pre-dilution to 0.57 in pure post-dilution (p=0.0004). Clearance, however, increased with decreasing pre-dilution fluid rate, from 53.9 ml/min at pure pre-dilution to 67.2 ml/min at 2 l/h pre-dilution with 4 l/h post-dilution. Conclusions: HVHF achieves high vancomycin clearances, which despite some deterioration in SC increase with the proportion of replacement fluid given post-filter. Clinicians applying HVHF need to be aware of such clearances to avoid inadequate vancomycin dosing and to adjust therapy according to variations in HVHF technique.

Original languageEnglish
Pages (from-to)1664-1667
Number of pages4
JournalIntensive Care Medicine
Volume28
Issue number11
DOIs
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Hemofiltration
Vancomycin
Septic Shock
Tertiary Care Centers
Intensive Care Units
Prospective Studies

Keywords

  • Acute renal failure
  • Clearance
  • Haemofiltration
  • Septic shock
  • Sieving coefficient
  • Vancomycin

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Clearance of vancomycin during high-volume haemofiltration : Impact of pre-dilution. / Uchino, Shigehiko; Cole, Louise; Morimatsu, Hiroshi; Goldsmith, Donna; Bellomo, Rinaldo.

In: Intensive Care Medicine, Vol. 28, No. 11, 2002, p. 1664-1667.

Research output: Contribution to journalArticle

Uchino, Shigehiko ; Cole, Louise ; Morimatsu, Hiroshi ; Goldsmith, Donna ; Bellomo, Rinaldo. / Clearance of vancomycin during high-volume haemofiltration : Impact of pre-dilution. In: Intensive Care Medicine. 2002 ; Vol. 28, No. 11. pp. 1664-1667.
@article{5104faea3fb546eab166b55ae49f8b76,
title = "Clearance of vancomycin during high-volume haemofiltration: Impact of pre-dilution",
abstract = "Objective: To measure the sieving coefficient (SC) and clearance of vancomycin during high-volume haemofiltration (HVHF) and to evaluate the impact of different pre-dilution regimens on these variables. Design and setting: Prospective interventional study in the intensive care unit in a tertiary university hospital. Patients: Seven patients with septic shock and multi-organ dysfunction. Interventions: HVHF (6 l/h fluid exchange) was performed in septic shock patients using variable proportions of their replacement fluid in pre- and post-dilution mode. Measurements and results: Pre-filter, post-filter and ultrafiltrate vancomycin concentrations were measured simultaneously, and SC and clearance calculated. The measurements were repeated following each change in the proportion of pre-dilution fluid. SC steadily decreased as the proportion of pre-dilution decreased, changing from 0.76 in pure pre-dilution to 0.57 in pure post-dilution (p=0.0004). Clearance, however, increased with decreasing pre-dilution fluid rate, from 53.9 ml/min at pure pre-dilution to 67.2 ml/min at 2 l/h pre-dilution with 4 l/h post-dilution. Conclusions: HVHF achieves high vancomycin clearances, which despite some deterioration in SC increase with the proportion of replacement fluid given post-filter. Clinicians applying HVHF need to be aware of such clearances to avoid inadequate vancomycin dosing and to adjust therapy according to variations in HVHF technique.",
keywords = "Acute renal failure, Clearance, Haemofiltration, Septic shock, Sieving coefficient, Vancomycin",
author = "Shigehiko Uchino and Louise Cole and Hiroshi Morimatsu and Donna Goldsmith and Rinaldo Bellomo",
year = "2002",
doi = "10.1007/s00134-002-1495-z",
language = "English",
volume = "28",
pages = "1664--1667",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Clearance of vancomycin during high-volume haemofiltration

T2 - Impact of pre-dilution

AU - Uchino, Shigehiko

AU - Cole, Louise

AU - Morimatsu, Hiroshi

AU - Goldsmith, Donna

AU - Bellomo, Rinaldo

PY - 2002

Y1 - 2002

N2 - Objective: To measure the sieving coefficient (SC) and clearance of vancomycin during high-volume haemofiltration (HVHF) and to evaluate the impact of different pre-dilution regimens on these variables. Design and setting: Prospective interventional study in the intensive care unit in a tertiary university hospital. Patients: Seven patients with septic shock and multi-organ dysfunction. Interventions: HVHF (6 l/h fluid exchange) was performed in septic shock patients using variable proportions of their replacement fluid in pre- and post-dilution mode. Measurements and results: Pre-filter, post-filter and ultrafiltrate vancomycin concentrations were measured simultaneously, and SC and clearance calculated. The measurements were repeated following each change in the proportion of pre-dilution fluid. SC steadily decreased as the proportion of pre-dilution decreased, changing from 0.76 in pure pre-dilution to 0.57 in pure post-dilution (p=0.0004). Clearance, however, increased with decreasing pre-dilution fluid rate, from 53.9 ml/min at pure pre-dilution to 67.2 ml/min at 2 l/h pre-dilution with 4 l/h post-dilution. Conclusions: HVHF achieves high vancomycin clearances, which despite some deterioration in SC increase with the proportion of replacement fluid given post-filter. Clinicians applying HVHF need to be aware of such clearances to avoid inadequate vancomycin dosing and to adjust therapy according to variations in HVHF technique.

AB - Objective: To measure the sieving coefficient (SC) and clearance of vancomycin during high-volume haemofiltration (HVHF) and to evaluate the impact of different pre-dilution regimens on these variables. Design and setting: Prospective interventional study in the intensive care unit in a tertiary university hospital. Patients: Seven patients with septic shock and multi-organ dysfunction. Interventions: HVHF (6 l/h fluid exchange) was performed in septic shock patients using variable proportions of their replacement fluid in pre- and post-dilution mode. Measurements and results: Pre-filter, post-filter and ultrafiltrate vancomycin concentrations were measured simultaneously, and SC and clearance calculated. The measurements were repeated following each change in the proportion of pre-dilution fluid. SC steadily decreased as the proportion of pre-dilution decreased, changing from 0.76 in pure pre-dilution to 0.57 in pure post-dilution (p=0.0004). Clearance, however, increased with decreasing pre-dilution fluid rate, from 53.9 ml/min at pure pre-dilution to 67.2 ml/min at 2 l/h pre-dilution with 4 l/h post-dilution. Conclusions: HVHF achieves high vancomycin clearances, which despite some deterioration in SC increase with the proportion of replacement fluid given post-filter. Clinicians applying HVHF need to be aware of such clearances to avoid inadequate vancomycin dosing and to adjust therapy according to variations in HVHF technique.

KW - Acute renal failure

KW - Clearance

KW - Haemofiltration

KW - Septic shock

KW - Sieving coefficient

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=0036903934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036903934&partnerID=8YFLogxK

U2 - 10.1007/s00134-002-1495-z

DO - 10.1007/s00134-002-1495-z

M3 - Article

C2 - 12583375

AN - SCOPUS:0036903934

VL - 28

SP - 1664

EP - 1667

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 11

ER -